Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - is the new guideline based on best evidence?

Míreanna comhchosúla

• Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - Is the new guideline based on best evidence?
  de réir: Canoy, D
  Foilsithe / Cruthaithe: (2014)
• Rethinking cardiovascular prevention: cost-effective cholesterol lowering for statin-intolerant patients in Australia and the UK
  de réir: Morton, JI, et al.
  Foilsithe / Cruthaithe: (2025)
• Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases
  de réir: Bahiru, E, et al.
  Foilsithe / Cruthaithe: (2017)
• Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?
  de réir: Preiss, D, et al.
  Foilsithe / Cruthaithe: (2017)
• [Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals].
  de réir: Zhang, D, et al.
  Foilsithe / Cruthaithe: (2011)